35
Participants
Start Date
April 28, 2015
Primary Completion Date
June 28, 2017
Study Completion Date
June 28, 2017
GSK2862277
"It is available as 26 milligrams (mg) white to off-white, uniform lyophilized cake that will be reconstituted (using reconstitution fluid formulated with polysorbate 80 in Water for Injection) to 40 mg/vial of Lyophile for reconstitution for inhalation with duration of nebulisation as approximately 3-5 min and will be administered using Pari eFlow with s30 mesh device."
Placebo
"It is a clear, colorless to pale yellow liquid, will be administered in volume to match active dose as solution for inhalation with duration of nebulisation as approximately 3-5 min and will be administered using Pari eFlow with s30 mesh device."
GSK Investigational Site, Cottingham
GSK Investigational Site, Belfast
GSK Investigational Site, Birmingham
GSK Investigational Site, Birmingham
GSK Investigational Site, Cambridge
GSK Investigational Site, Middlesbrough
Lead Sponsor
GlaxoSmithKline
INDUSTRY